🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track cancer catalysts with approval-probability scores and free alerts.

Oncology Biotech Pipeline: Cancer Drugs in Clinical Development

Every cancer program BioRadar tracks across 303 public biotech companies — drug candidates, trial phases and upcoming FDA decisions. Updated automatically.

BioRadar is tracking 3912 cancer drug programs across 303 public companies, with 3 upcoming FDA decisions in this area. The most active companies by program count are IBRX, MRK, SNDX, BNTX, KPTI.

3912Drug programs
303Companies
885In Phase 3
3Upcoming FDA dates

Upcoming FDA decisions in Oncology (Cancer)

DateTickerDrug / IndicationTypeIn
Dec 23, 2026 GILD anito-cel — relapsed or refractory multiple my BLA 46d
Apr 14, 2027 INBX ozekibart — unresectable or metastatic convent BLA 158d
Apr 28, 2027 IMNM Varegacestat — adults with desmoid tumors and ass NDA 172d

See all upcoming FDA decisions in the PDUFA calendar →

Companies with cancer programs

IBRX 98 programs MRK 85 programs SNDX 81 programs BNTX 71 programs KPTI 70 programs GMAB 69 programs BMY 67 programs NKTR 61 programs ONC 59 programs ABBV 58 programs AZN 54 programs RCUS 54 programs AGEN 53 programs IOVA 52 programs MGNX 52 programs CLDX 51 programs GILD 49 programs JAZZ 49 programs NVS 47 programs IMTX 45 programs PFE 45 programs VSTM 44 programs SMMT 43 programs EXEL 41 programs LLY 40 programs PBYI 40 programs ZLAB 40 programs INCY 39 programs ADCT 38 programs ONCY 37 programs RVMD 37 programs AAPG 32 programs ADAG 32 programs HCM 32 programs HALO 31 programs REGN 31 programs FATE 29 programs MYGN 29 programs TCRT 29 programs XNCR 29 programs CHRS 28 programs LEGN 28 programs IMCR 27 programs TCRX 27 programs AMGN 26 programs KURA 25 programs ACHV 24 programs ALXO 24 programs TGTX 24 programs IBO 23 programs ACTU 22 programs IDYA 22 programs INBX 22 programs NCNA 22 programs CELC 21 programs REPL 21 programs TLX 21 programs TPST 21 programs ARVN 20 programs IPHA 20 programs ANL 19 programs BLRX 19 programs CRDF 19 programs GSK 19 programs IMMP 19 programs IMNN 19 programs RNA 19 programs TAK 19 programs APVO 18 programs CORT 18 programs NXTC 18 programs ORIC 18 programs CRIS 17 programs ERAS 17 programs INO 17 programs JNJ 17 programs LNTH 17 programs NUVB 17 programs URGN 17 programs ZYME 17 programs SBFM 16 programs AIM 15 programs EIKN 15 programs MRKR 15 programs ZNTL 15 programs CADL 14 programs GERN 14 programs LGND 14 programs ATNM 13 programs CMPS 13 programs CMPX 13 programs COGT 13 programs LSTA 13 programs MEDP 13 programs RIGL 13 programs SNY 13 programs ACOG 12 programs ADPT 12 programs CGEM 12 programs CNTX 12 programs GNPX 12 programs OLMA 12 programs PRLD 12 programs SLS 12 programs STRO 12 programs TKNO 12 programs APRE 11 programs BCTX 11 programs CTMX 11 programs ELVN 11 programs PBH 11 programs VERU 11 programs CELU 10 programs CRVS 10 programs GALT 10 programs GNLX 10 programs KZIA 10 programs LTRN 10 programs MBIO 10 programs TRAW 10 programs ALLR 9 programs ARTV 9 programs CATX 9 programs CGEN 9 programs CLRB 9 programs IMRX 9 programs IQV 9 programs KYNB 9 programs LYEL 9 programs MOLN 9 programs NRIX 9 programs NUVL 9 programs TNGX 9 programs TVRD 9 programs AVBP 8 programs BYSI 8 programs CAH 8 programs CCCC 8 programs ICLR 8 programs TOVX 8 programs ACRS 7 programs AUTL 7 programs CRBP 7 programs MAIA 7 programs OKUR 7 programs RNAC 7 programs STTK 7 programs AGIO 6 programs APLM 6 programs ASND 6 programs ATRA 6 programs BOLD 6 programs BOLT 6 programs CGON 6 programs CLLS 6 programs INTS 6 programs KRYS 6 programs MBRX 6 programs PGEN 6 programs RNAZ 6 programs TYRA 6 programs VIR 6 programs XLO 6 programs BCAX 5 programs BHVN 5 programs BTAI 5 programs CRBU 5 programs EVAX 5 programs FTH 5 programs GENB 5 programs JANX 5 programs NERV 5 programs PBLS 5 programs VRCA 5 programs ACET 4 programs ALLO 4 programs BLSM 4 programs CRSP 4 programs CVM 4 programs GLSI 4 programs GOSS 4 programs PTCT 4 programs PYXS 4 programs RADX 4 programs RXRX 4 programs SLN 4 programs TLSA 4 programs XBIT 4 programs ACRV 3 programs ANIX 3 programs APGE 3 programs ARGX 3 programs ATOS 3 programs AURA 3 programs BDTX 3 programs BKHA 3 programs BTTC 3 programs CANF 3 programs CUE 3 programs DTIL 3 programs EBS 3 programs ELTX 3 programs ENGN 3 programs FHTX 3 programs GLUE 3 programs HOWL 3 programs HRTX 3 programs IRLA 3 programs LXRX 3 programs MCRB 3 programs MNPR 3 programs NBTX 3 programs NVCT 3 programs OGN 3 programs OPK 3 programs PCSA 3 programs RDHL 3 programs RNXT 3 programs SNGX 3 programs TEVA 3 programs TIL 3 programs VOR 3 programs XCUR 3 programs XFOR 3 programs AKTS 2 programs ALDX 2 programs ALNY 2 programs ALVO 2 programs ARCT 2 programs BCRX 2 programs BEAM 2 programs BFRI 2 programs CYTK 2 programs DMRA 2 programs DRUG 2 programs ENLV 2 programs GDTC 2 programs GOVX 2 programs HCWB 2 programs HURA 2 programs IBIO 2 programs IMMX 2 programs INAB 2 programs INDP 2 programs KAPA 2 programs KYMR 2 programs LONA 2 programs MESO 2 programs MREO 2 programs NGNE 2 programs PLRX 2 programs PMVP 2 programs QGEN 2 programs RDY 2 programs RLMD 2 programs RZLT 2 programs SANA 2 programs SRRK 2 programs TARA 2 programs XBIO 2 programs ABUS 1 program ABVX 1 program AMRX 1 program AVTX 1 program BCYC 1 program BHC 1 program BMEA 1 program BNTC 1 program CBIO 1 program CTOR 1 program CTXR 1 program ENTX 1 program EOCN 1 program ESLA 1 program FENC 1 program FMS 1 program GRFS 1 program IAM 1 program IFRX 1 program IMDX 1 program IMNM 1 program IMUX 1 program INKT 1 program INMB 1 program MGTX 1 program MNKD 1 program OBX 1 program OSTX 1 program PDSB 1 program PHIO 1 program PPBT 1 program PRAX 1 program PRGO 1 program QNTM 1 program QUCY 1 program RGEN 1 program RLAY 1 program SGMT 1 program SNTI 1 program TELO 1 program VTRS 1 program VTVT 1 program WHWK 1 program

Phase 3 oncology (cancer) programs (885)

TickerDrugIndication
AAPG Bosutinib Chronic Myeloid Leukemia
AAPG Azacitidine Injection Acute Myeloid Leukemia
AAPG APG-2575(Lisaftoclax ) Acute Myeloid Leukemia
ABBV Venetoclax Acute Myeloid Leukemia
ABBV Azacitidine Acute Myeloid Leukemia
ABBV Pivekimab Sunirine Acute Myeloid Leukemia
ABBV Telisotuzumab Vedotin Non Small Cell Lung Cancer
ABBV Docetaxel Non Small Cell Lung Cancer
ABBV Epcoritamab Diffuse Large B-cell Lymphoma
ABBV Cytarabine Acute Myeloid Leukemia
ABBV Investigator's Choice Chemotherapy Diffuse Large B-cell Lymphoma
ABBV Fludarabine Acute Myeloid Leukemia
ABBV Gemtuzumab Ozogamicin Acute Myeloid Leukemia
ACHV Docetaxel Non-Small Cell Lung Cancer
ACHV Custirsen Non-Small Cell Lung Cancer
ACHV Prednisone Prostate Cancer
ACHV Dexamethasone Prostate Cancer
ACHV cabazitaxel Prostate Cancer
ACHV custirsen sodium Prostate Cancer
ACHV isotonic, 0.9% sodium chloride Castrate-Resistant Prostate Cancer
ACHV TOCOSOL Paclitaxel Breast Neoplasm
ACHV Taxol Breast Neoplasm
ACOG trifluridine and tipiracil Colorectal Neoplasms
ACOG AZD3759 Non-small Cell Lung Cancer
ACOG Erlotinib Non-small Cell Lung Cancer
ACOG Gefitinib Non-small Cell Lung Cancer
ADCT Rituximab B-cell Non Hodgkin Lymphoma
ADCT Gemcitabine Relapsed Diffuse Large B-Cell Lymphoma
ADCT Oxaliplatin Relapsed Diffuse Large B-Cell Lymphoma
ADCT Etoposide B-cell Non Hodgkin Lymphoma
ADCT Dexamethasone B-cell Non Hodgkin Lymphoma
ADCT CAR T-cells (TBC) B-cell Non Hodgkin Lymphoma
ADCT Ifosfamide B-cell Non Hodgkin Lymphoma
ADCT Etoposide Phosphate B-cell Non Hodgkin Lymphoma
ADCT Carboplatin B-cell Non Hodgkin Lymphoma
ADCT Odronextamab B-cell Non Hodgkin Lymphoma
ADCT Loncastuximab tesirine B-cell Non Hodgkin Lymphoma
AGEN balstilimab Resectable MMR-deficient Solid Tumors
AGEN botensilimab Resectable MMR-deficient Solid Tumors
AGEN Gemcitabine Advanced Cancer

Phase 2 oncology (cancer) programs (1925)

TickerDrugIndication
AAPG APG-115 Liposarcoma
AAPG APG-2575 Chronic Lymphocytic Leukemia
AAPG Brentuximab Vedotin (Bv) Cutaneous T-Cell Lymphoma/Mycosis Fungoides
AAPG Carboplatin Malignant Salivary Gland Cancer
AAPG standard-dose HHT Relapsed/Refractory Acute Myeloid Leukaemia
AAPG Azacitidine Relapsed/Refractory Acute Myeloid Leukaemia
AAPG Reduced-dose HHT Relapsed/Refractory Acute Myeloid Leukaemia
AAPG HQP1351 Chronic Myeloid Leukemia, Chronic Phase
AAPG APG2575 Chronic Lymphocytic Leukemia
AAPG Gemcitabine Advanced Pancreatic Cancer
AAPG APG-1387 for Injection Advanced Solid Tumor
AAPG Nab paclitaxel Advanced Pancreatic Cancer
AAPG Toripalimab Liposarcoma
AAPG Phase 1b: APG-115+pembrolizumab Unresectable or Metastatic Melanoma or Advanced So
AAPG Ibrutinib Chronic Lymphocytic Leukemia
AAPG Hydroxyurea or Interferon-based therapy Chronic Myeloid Leukemia, Chronic Phase
AAPG Homoharringtonine Chronic Myeloid Leukemia, Chronic Phase
AAPG Imatinib, Dasatinib or Nilotinib Chronic Myeloid Leukemia, Chronic Phase
AAPG Palbociclib Breast Cancer
AAPG APG-2575 + DRd Multiple Myeloma
AAPG APG-2575+ Pd Multiple Myeloma
AAPG Rd Multiple Myeloma
ABBV Bevacizumab Metastatic Colorectal Cancer
ABBV Budigalimab Non Small Cell Lung Carcinoma
ABBV ABBV-706 Small Cell Lung Cancer
ABBV Lurbinectedin Small Cell Lung Cancer
ABBV Atezolizumab Small Cell Lung Cancer
ABBV Carboplatin Small Cell Lung Cancer
ABBV Pirtobrutinib Mantle Cell Lymphoma
ABBV Rituximab Mantle Cell Lymphoma
ABBV Cisplatin Head and Neck Squamous Cell Carcinoma
ABBV Pembrolizumab Head and Neck Squamous Cell Carcinoma
ABBV Pemetrexed Non Small Cell Lung Carcinoma
ABBV Fluorouracil Metastatic Colorectal Cancer
ABBV Leucovorin Metastatic Colorectal Cancer
ABBV Panitumumab Metastatic Colorectal Cancer
ABBV Oxaliplatin Metastatic Colorectal Cancer
ABBV Etoposide Small Cell Lung Cancer
ABBV Dexamethasone Multiple Myeloma
ABBV Daratumumab Multiple Myeloma

Phase 1 oncology (cancer) programs (991)

TickerDrugIndication
AAPG Decitabine Advanced Chronic Myeloid Leukemia
AAPG Listaftoclax Advanced Chronic Myeloid Leukemia
AAPG APG-2449 Advanced Solid Cancer
AAPG PLD Platinum-resistant Recurrent Ovarian Cancer
AAPG APG -2449 Platinum-resistant Recurrent Ovarian Cancer
AAPG Ascentage Pharma HQP1351 bioavailable in Leukemia, Myeloid, Chronic
AAPG Osimertinib Mesylate Tablets EGFR Positive Non-small Cell Lung Cancer
ABBV Selinexor Diffuse Large B-cell Lymphoma
ABBV Daunorubicin Acute Myeloid Leukemia
ABBV ABBV-101 Hematologic Cancer
ACET ADI-270 Clear Cell Renal Cell Carcinoma
ACHV Custirsen, paclitaxel and carboplatin Cancer
ACHV SN2310 Injectable Emulsion Breast Neoplasms
ACOG [14C]Zorifertinib Oral Formulation EGFR Mutant Advanced Non-small Cell Lung Cancer
ACOG Zorifertinib and Osimertinib Combination Patients With Advanced Non-small Cell Lung Cancer
ACOG [211At]NaAt DTC - Differentiated Thyroid Cancer
ACRS Zunsemetinib Metastatic Pancreatic Ductal Adenocarcinoma
ACRS mFOLFIRINOX Metastatic Pancreatic Ductal Adenocarcinoma
ACRS ATI-2231 Advanced Solid Tumor
ACTU Chemotherapy Pancreatic Adenocarcinoma
ACTU Topotecan Refractory Cancer
ACTU Cyclophosphamide Refractory Cancer
ACTU Temozolomide Refractory Cancer
ADAG ADG206 Advanced/Metastatic Solid Tumors
ADAG anti PD1 drug Advanced/Metastatic Solid Tumors
ADAG ADG116 Advanced/Metastatic Solid Tumors
ADCT Loncastuximab tesirine and rituximab (Lo Central Nervous System Lymphoma
ADCT Mosunetuzumab B-Cell Non-Hodgkin Lymphoma
ADCT Glofitamab B-Cell Non-Hodgkin Lymphoma
ADCT Polatuzumab Vedotin B-Cell Non-Hodgkin Lymphoma
ADCT Obinutuzumab B-Cell Non-Hodgkin Lymphoma
ADCT Loncastuximab Tesirine and Acalabrutinib Chronic Lymphocytic Leukemia
ADCT ADCT-901 Advanced Solid Tumors
ADCT ADCT-601 Advanced Solid Tumors
ADCT Pembrolizumab Head and Neck Cancer Squamous Cell Carcinoma
ADCT Melphalan Recurrent Diffuse Large B-Cell Lymphoma
ADCT Carmustine Recurrent Diffuse Large B-Cell Lymphoma
ADCT Cytarabine Recurrent Diffuse Large B-Cell Lymphoma
ADCT Loncastuximab Tesirine and Durvalumab Diffuse Large B-Cell Lymphoma
ADCT ADCT-402 Acute Lymphoblastic Leukemia

Track cancer catalysts before they hit

BioRadar scores every upcoming FDA decision with an AI Probability of Approval, tracks cash runway and dilution risk, and sends free email alerts. Build a cancer watchlist in minutes.

Start free →
Data: ClinicalTrials.gov, SEC & FDA filings • Informational only, not investment advice. • All biotech stocks A–Z →

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.

⚠️ This data is for informational purposes only, not investment advice. Always do your own research.